OTCMKTS:AVCNF Avicanna (AVCNF) Stock Price, News & Analysis $0.08 +0.00 (+2.14%) As of 10/13/2026 01:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Avicanna Stock (OTCMKTS:AVCNF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avicanna alerts:Sign Up Key Stats Today's Range$0.08▼$0.0850-Day Range$0.07▼$0.1052-Week Range$0.06▼$0.21Volume100 shsAverage Volume75,278 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Avicanna Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of cannabinoid-based products and therapies. The company applies pharmaceutical research and formulation expertise to create products designed for medical, wellness and consumer applications. Avicanna’s activities include cannabinoid research, cultivation and processing support, product formulation, clinical development and commercialization. Its offerings have included medical cannabis products, pharmaceutical preparations and cannabinoid-based topical and wellness products, including products marketed under the RHO Phyto brand in Canada. The company has historically maintained operations and commercial relationships in Canada and Colombia, supporting its research, cultivation, manufacturing and distribution activities. Avicanna is led by Chief Executive Officer Aras Azadian and is headquartered in Toronto, Ontario.AI Generated. May Contain Errors. Read More Receive AVCNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avicanna and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVCNF Stock News HeadlinesAvicanna Inc. (OTCMKTS:AVCNF) Sees Significant Drop in Short InterestOctober 13 at 1:43 AM | americanbankingnews.comAvicanna to Present at a Life Sciences Investor Forum on September 17, 2026September 15, 2026 | globenewswire.comElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into millionaires. One welder's $10,000 stock package made him a millionaire on IPO day. Former Wall Street CEO Dylan Jovine says Elon Musk's next venture could outsize everything he's built before. It runs on an obscure AI firm Musk has relied on since 2012, supplying crucial technology to Tesla, Starlink and SpaceX.October 14 at 1:00 AM | Behind the Markets (Ad)Avicanna Launches MyMedi.ca Integrated Healthcare Program in CanadaSeptember 9, 2026 | globenewswire.comAvicanna Inc.August 26, 2026 | marketwatch.comAvicanna Secures Strategic Private Placement Led by Pharma Investor Michael PorterAugust 19, 2026 | tipranks.comAvicanna Announces Closing of Strategic Non-Brokered Private PlacementAugust 19, 2026 | financialpost.comFAvicanna Announces Closing of Strategic Non-Brokered Private PlacementAugust 19, 2026 | globenewswire.comSee More Headlines AVCNF Stock Analysis - Frequently Asked Questions How have AVCNF shares performed this year? Avicanna's stock was trading at $0.1621 on January 1st, 2026. Since then, AVCNF shares have decreased by 53.0% and is now trading at $0.0762. How do I buy shares of Avicanna? Shares of AVCNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:AVCNF Previous SymbolOTC:AVCNF CIKN/A Webwww.avicanna.com Phone1.647.243.5283FaxN/AEmployees87Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:AVCNF) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThis AI fund posted a 34 percent annualized payout last monthOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...Decentralized Masters | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avicanna Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avicanna With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.